.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Moodys
Mallinckrodt
UBS
Johnson and Johnson
Farmers Insurance
Federal Trade Commission
US Department of Justice
Accenture
Cerilliant
Citi

Generated: June 28, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 087954

« Back to Dashboard
NDA 087954 describes VITAMIN K1, which is a drug marketed by Hospira and is included in three NDAs. It is available from three suppliers. Additional details are available on the VITAMIN K1 profile page.

The generic ingredient in VITAMIN K1 is phytonadione. There are nine drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the phytonadione profile page.

Summary for NDA: 087954

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 087954

Suppliers and Packaging for NDA: 087954

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VITAMIN K1
phytonadione
INJECTABLE;INJECTION 087954 ANDA Hospira, Inc. 0409-9157 0409-9157-01 5 TRAY in 1 CONTAINER (0409-9157-01) > 5 AMPULE in 1 TRAY > .5 mL in 1 AMPULE
VITAMIN K1
phytonadione
INJECTABLE;INJECTION 087954 ANDA Hospira, Inc. 0409-9157 0409-9157-25 5 TRAY in 1 CONTAINER (0409-9157-25) > 5 AMPULE in 1 TRAY > .5 mL in 1 AMPULE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/0.5ML
Approval Date:Jul 25, 1983TE:BPRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Colorcon
Merck
Healthtrust
Cantor Fitzgerald
US Army
AstraZeneca
Federal Trade Commission
McKinsey
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot